Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023
   PCE(x) -970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is -970.75 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹92.5 Cr -5.7% -12.1% -31.5% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹9,255.9 Cr -1.7% -13.1% 25.4% Stock Analytics
KIRI INDUSTRIES ₹3,295.5 Cr -3.7% -1% 50% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,694.9 Cr -1.4% -4.3% -25.1% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,361.1 Cr 1.3% -4.5% 71.6% Stock Analytics
BODAL CHEMICALS ₹768.8 Cr 0.4% -1.9% -16.7% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-5.7%

-12.1%

-31.5%

SENSEX

-0.2%

5%

5.4%


You may also like the below Video Courses